Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial
- PMID: 24756510
- PMCID: PMC6145171
- DOI: 10.1001/jama.2014.3325
Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial
Conflict of interest statement
Comment on
-
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312. JAMA. 2014. PMID: 24756514 Free PMC article. Clinical Trial.
References
-
- Mann T, Keilin D. Sulphanilamide as a specific inhibitor of carbonic anhydrase. Nature. 1940;146:164–165.
-
- Roblin RO, Clapp JW. The preparation of heterocyclic sulfonamides. J Am Chem Soc. 1950;72:4890–4892.
-
- Birzis L, Carter CH, Maren TH. Effects of acetazolamide on CSF pressure and electrolytes in hydrocephalus. Neurology. 1958;8(7):522–528. - PubMed
-
- Lueck C McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev. 2005;(3):CD003434. - PubMed
-
- The NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the Idiopathic Intracranial Hypertension Treatment Trial. JAMA. doi:10.1001/jama.2014.3312. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical